On 23 February, Alzheimer Europe hosted an online Company Round Table meeting, attended by representatives from Biogen, Eisai, EFPIA, Grifols, Nutricia, Roche and TauRx. Also in attendance, were: 7 members of the AE staff, including Executive Director Jean Georges; 19 representatives of AE member organisations from 16 different countries; and 1 representative of the European Working Group of People with Dementia (EWGPWD).
Project Officer Cindy Birck gave an overview of recent developments with regards our Clinical Trials Watch database. Policy Officer Owen Miller shared some recent policy developments at the WHO and EU levels on WHO Non-Communicable disease activities, WHO Global Action Plan on Dementia EU4Health Programme and Horizon Europe. Audrey Wolf and Thomas Allvin, two representatives from EFPIA, then presented the EU Pharmaceutical Strategy with general principles and opportunities for Alzheimer’s medicines. Finally, Jean Georges updated sponsors and other delegates on Alzheimer Europe’s activities. We would like to thank our sponsors and members for participating in this meeting and we look forward to welcoming them to the next Company Round Table meeting, on 16 June 2021.
